FDA-Approved vs Research Compounds Understanding the distinction between FDA-approved peptides and research-only compounds is essential for evaluating safety: Category Examples Evidence Base Regulation FDA-Approved Semaglutide (Ozempic), Teriparatide (Forteo), Tesamorelin (Egrifta) Phase I-III clinical trials, post-market surveillance Prescription required, manufactured under cGMP Previously Approved Sermorelin (Geref withdrawn 2008) Clinical trial data exists, but product no longer marketed Research use only (currently) Research Only BPC-157, TB-500, Ipamorelin, KPV Preclinical data (varying depth), no completed human trials Sold for laboratory research, not human consumption For the complete list of FDA-approved peptides and their indications, see our FDA Approved Peptides List 2026 guide
This broad gene regulatory activity establishes a cellular environment primed for regeneration, with research demonstrating that GHK-Cu treatment resets aged gene expression patterns to match younger, healthier profiles
The news and editorial staff of the Times Standard had no role in this posts preparation
This timing allows AMPK activation to proceed without NAD+ limitation, maximising mitochondrial biogenesis and fat oxidation
Sometimes an oral vitamin can further upset the stomach, so be aware that this is a possible side effect
Hydroxocobalamin is the preferred agent in this patient population (see separate monograph in Less Common Drugs)
